The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ENETS 2021 | The direction of future NET research
Enrique Grande MD, PhD, MD Anderson Cancer Centre Madrid, Madrid, Spain, discusses the critical research into neuroendocrine tumors (NETs) that is needed in the future, particularly the significance of biomarker discovery and combining strategies to improve response rates. Dr Grande also emphasizes the importance of conducting research that will directly shape treatment in clinical practice, as the international guidelines lack clarity for use in a clinical setting. This interview took place during the European Neuroendocrine Tumor Society (ENETS) 19th Annual Conference 2021.
